2015 ACR-EULAR痛风分类标准在基层医疗单关节炎人群中的表现
该研究在荷兰家庭医生接诊的381例单关节炎患者中,以关节液MSU晶体为参照,验证2015 ACR-EULAR痛风分类标准的诊断性能。全版本(含关节液分析)和仅临床版本的AUC分别为0.96和0.87,特异性高(0.98和0.84)但敏感性较低(均为0.68);2010年诊断决策规则敏感性最高(0.99)。
要点
- 全版本标准AUC 0.96,特异性0.98,PPV 0.98,敏感性0.68,NPV 0.70。
- 仅临床版本AUC 0.87,特异性0.84,PPV 0.84,敏感性0.68,NPV 0.67。
- 2010年诊断决策规则敏感性0.99、NPV 0.97,但特异性0.71、PPV 0.89。
核心结论
- 2015 ACR-EULAR痛风分类标准在基层医疗单关节炎患者中用于临床试验入组时表现良好。
研究设计与样本
- 对荷兰家庭医生连续接诊的单关节炎患者现有数据集应用该标准,所有患者均接受关节液显微镜分析,数据于2010年前瞻性收集用于开发痛风诊断决策规则。
主要发现
- 381例入组患者中216例(57%)MSU晶体阳性。
- 全版本标准AUC为0.96,特异性0.98,PPV 0.98,敏感性0.68,NPV 0.70。
- 仅临床版本AUC为0.87,特异性0.84,PPV 0.84,敏感性0.68,NPV 0.67。
- 两版本特异性和PPV均高于2010年诊断决策规则的0.71和0.89。
- 2010年诊断决策规则敏感性0.99、NPV 0.97为最高。
关键数值与推荐
- 全版本标准(含关节液分析)AUC 0.96,特异性0.98,PPV 0.98,敏感性0.68,NPV 0.70。
- 仅临床版本(不含关节液分析)AUC 0.87,特异性0.84,PPV 0.84,敏感性0.68,NPV 0.67。
- 2010年诊断决策规则特异性0.71,PPV 0.89,敏感性0.99,NPV 0.97。
临床怎么用
- 在基层单关节炎患者中,该分类标准高特异性有助于确认痛风用于临床试验入组,但敏感性较低需注意漏诊。
- 仅临床版本可在无关节液分析时使用,但特异性与PPV低于全版本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the performance of the 2015 ACR-EULAR gout classification criteria against presence of SF MSU crystals in a primary healthcare population. METHODS: The criteria were applied to an existing dataset of consecutive patients with monoarthritis presenting to Dutch family physicians; all patients underwent microscopic SF analysis by design. The data had been prospectively collected to develop a diagnostic decision rule for gout in 2010. Diagnostic performance was assessed by calculating area under the receiver operating characteristic curve, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and constructing calibration plots for the full version of the criteria (including SF analysis results of all patients) and the clinical-only version (not including SF analysis results). Performance of both versions was compared with the 2010 diagnostic rule. RESULTS: Of 381 patients enrolled into the study, 216 (57%) were MSU crystal-positive. The full and clinical-only versions of the criteria had satisfactory area under the receiver operating characteristic curve (0.96 and 0.87, respectively), high specificity (0.98 and 0.84), high PPV (0.98 and 0.84), but lower sensitivity (0.68 and 0.68) and NPV (0.70 and 0.67). Specificity and PPV of both versions were higher compared with 0.71 and 0.89 of the 2010 diagnostic decision rule. The decison rule had the highest sensitivity and NPV (0.99 and 0.97). CONCLUSION: This study presents the first external validation of the 2015 ACR-EULAR gout classification criteria in a primary healthcare setting. The criteria perform well in this setting in patients presenting with monoarthritis for the purpose of enrolling into gout clinical trials.
引用
- Janssens HJEM, Fransen J, Janssen M, et al. Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis. Rheumatology (Oxford). 2017. PMID: 28431109. doi:10.1093/rheumatology/kex164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。